Role of Angiotensin Converting Enzyme Inhibitors in Essential and Renal Hypertension
- 1 August 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (2) , 43-51
- https://doi.org/10.1016/s0002-9343(84)80057-1
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Inhibitors of the Renin-Angiotensin SystemAmerican Journal of Nephrology, 1983
- CaptoprilNew England Journal of Medicine, 1982
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".The Lancet, 1981
- Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.BMJ, 1981
- Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captoprilAmerican Heart Journal, 1981
- Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.British Journal of Clinical Pharmacology, 1981
- CaptoprilDrugs, 1980
- Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.Hypertension, 1979
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977